knowledge -WSS

knowledge

author：leisure time 2025-09-06 02:16:32 - browse：79

Feng Zhang Editas — Aera was formed to pursue a nanoparticle described by Feng Zhang in 2021. Susan Walsh/AP

Aera Therapeutics, a startup launched by the CRISPR pioneer Feng Zhang last year to solve one of the biggest bottlenecks in genetic medicine, has laid off a quarter of its staff, the company confirmed to STAT.

The layoffs come as the biotech market remains mired in a now nearly three-year-long downturn that has left startups struggling to attract both private and public funds. Aera attributed the layoffs to those headwinds and indicated it had axed a portion of the company dedicated to developing new gene-editing enzymes.

“In 2023, Aera launched to pursue an ambitious mission to develop transformative genetic medicines by harnessing enabling delivery technologies and precision payloads,” spokesman Dan Budwick said in a statement. “Although Aera remains in a strong cash position today, given the current biotech funding environment, we have chosen to take steps to focus our strategy and investments on the development of our novel delivery platforms, thereby further extending our cash runway.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： New definition of a human embryo proposed amid rapid advances

hotspot

WSS

FDA approves first treatment for ultra

Hilary expected to bring catastrophic, life

As digital health tech proliferates, a new institute aims to cut through hype

Trump's false claims about Georgia's 2020 election long debunked

Custom gene therapy hints at new path for rare disease treatments

At Orexo, a ‘turning point’ for everything but digital health

focus

knowledge

explore

What does generative AI mean for health care? We asked experts

A public scorecard can help hold safety

Drug repurposing or repositioning? The language matters

The boys, now 6, who are gene therapy’s ‘edge case’ problem

Wildfire smoke exposes gaps in outdoor worker protections

STAT Virtual Event: The State of Biosimilars: What to Watch

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

Medical leaders decry Supreme Court decision on affirmative action

Living with Hashimoto's and celiac disease, and med school, too

knowledge

Evacuations in place as 3 wildfires burn in eastern Washington state

Majority of Americans think Trump's Ga. election interference case is serious: POLL

Hilary may become 1st tropical storm to make landfall in California in 84 years

How Medicaid coverage policies for immigrants impact new moms

Medicare to cover more brain scans for Alzheimer’s patients

Biden tests positive for Covid

explore

hotspot

leisure time

leisure time